Lada Rasochova
Dermala Inc., University of California, USA
Scientific Tracks Abstracts: J Dermatol Dis
From skincare to haircare, a new class of tech-driven dermatology applications has emerged in the market that allows consumers to access beauty and dermatology products personalized for their specific needs and self-treat their issues in real time. Dermala focuses on the most prevalent skin diseases like acne and eczema, skin conditions like skin aging. It is developing end-to-end solutions that consist of a mobile app for tracking the treatment outcome and treatment optimization. We use data analytics, machine learning and artificial intelligence to personalized topical and oral treatments for specific conditions and individual customer needs. Incorporating digital health approach allows us to track customersâ?? treatment progress, educate them about their condition and provide support if they have any questions. We use the tracking data and outcomes to personalize and optimize treatments and adjust and optimize products and treatment routines based on actual results. This leads to better outcomes, higher treatment compliance and higher customer retention and satisfaction.
Lada Rasochova is currently a CEO of Dermala Inc., a spinout from the University of California in San Diego and Executive Director and the California Institute for Innovation and Development and also a Faculty Member at UC San Diego. She has completed her PhD in Molecular, Cellular and Developmental Biology from Iowa State University and Post-doctoral studies in Virology at the University of Wisconsin Madison. She has 25 years of experience from pharmaceutical and biotechnology industry in developing therapeutics, vaccines, anti-microbial and microbial production systems for pharmaceutical applications.
E-mail: rasochova@dermala.com
Journal of Dermatology and Dermatologic Diseases received 4 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 